Press release
Axillary Hyperhidrosis Pipeline Drugs 2024 | GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical
Discover the latest drugs and treatment options in the Axillary Hyperhidrosis Pipeline. Dive into DelveInsight's comprehensive report today! @ Axillary Hyperhidrosis Pipeline Outlook [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Axillary Hyperhidrosis Pipeline Report
* January 2024:- InMode MD Ltd.- The InMode radio frequency Pro System with the Morpheus8 Applicator is a computerized system generating radio frequency energy, based on the underlying technology of Fractional RF. The Morpheus8 Applicator and 24 pin tip is used for the treatment of primary hyperhidrosis of the axillae.
* DelveInsight's Axillary Hyperhidrosis pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Axillary Hyperhidrosis treatment.
* The leading Axillary Hyperhidrosis Companies such as GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical, and others.
* Promising Axillary Hyperhidrosis Therapies such as Sofpironium bromide, ET-01, DMT410, and others.
Stay ahead with the most recent pipeline outlook for Axillary Hyperhidrosis. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Axillary Hyperhidrosis Treatment Drugs [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Axillary Hyperhidrosis Emerging Drugs
* Sofpironium bromide: Brickell Biotech Inc.
Sofpironium bromide is a new chemical entity that we are currently developing in the U.S. as a potential best-in-class, self-administered, once-daily, topical therapy for the treatment of primary axillary hyperhidrosis, or excessive underarm sweating. The drug is a retro metabolically designed anticholinergic agent which selectively binds to M3 AC receptor potentially inhibiting sweat production.
* ET-01: Eirion Therapeutics
ET-01 is a topical botulinum product being developed with the goal of avoiding the pain, bleeding and bruising that can be associated with the injection of commercially available botulinum products. ET-01 employs a nanoemulsion transdermal delivery technology essential for a large molecule such as botulinum to penetrate into the skin.The drug is currently being developed in Phase 2 stage of development for the treatment of Axillary Hyperhidrosis.
* DMT410: Dermata Therapeutics LLC pipeline
DMT410 is the second development program using DMT400 combination regimen in combination with botulinum toxin. Dermata Therapeutics have completed a proof of concept, Phase 1 clinical trial using DMT410 in combination with BOTOX Registered for the treatment of primary axillary hyperhidrosis. The treatment was well tolerated, and a majority of patients saw a reduction in sweat production similar to results seen from using injections of BOTOX Registered .
Explore groundbreaking therapies and clinical trials in the Axillary Hyperhidrosis Pipeline. Access DelveInsight's detailed report now! @ New Axillary Hyperhidrosis Drugs [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Axillary Hyperhidrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Axillary Hyperhidrosis Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Unveil the future of Axillary Hyperhidrosis Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Axillary Hyperhidrosis Market Drivers and Barriers [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Axillary Hyperhidrosis Pipeline Report
* Coverage- Global
* Axillary Hyperhidrosis Companies- GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical, and others.
* Axillary Hyperhidrosis Therapies- Sofpironium bromide, ET-01, DMT410, and others.
* Axillary Hyperhidrosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Axillary Hyperhidrosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Axillary Hyperhidrosis Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Axillary Hyperhidrosis Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/axillary-hyperhidrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Axillary Hyperhidrosis: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Axillary Hyperhidrosis- DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Sofpironium bromide: Brickell Biotech Inc
* Drug profiles in the detailed report.....
* Last Stage Products (Phase III)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* ET-01: Eirion Therapeutics
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Axillary Hyperhidrosis Key Companies
* Axillary Hyperhidrosis Key Products
* Axillary Hyperhidrosis - Unmet Needs
* Axillary Hyperhidrosis - Market Drivers and Barriers
* Axillary Hyperhidrosis - Future Perspectives and Conclusion
* Axillary Hyperhidrosis Analyst Views
* Axillary Hyperhidrosis Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=axillary-hyperhidrosis-pipeline-drugs-2024-glaxosmithkline-medytox-theravida-candesant-biomedical]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axillary Hyperhidrosis Pipeline Drugs 2024 | GlaxoSmithKline, Medytox, Theravida, Candesant Biomedical here
News-ID: 3635377 • Views: …
More Releases from ABNewswire
Hanley Investment Group Arranges $9.2 Million Sale of Starbucks-Anchored Strip C …
SAN JUAN CAPISTRANO, Calif. - Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today the sale of Rancho Ortega Plaza, a two-story, 23,122-square-foot strip center anchored by Starbucks in San Juan Capistrano, California. The property sold for $9.2 million to a private 1031 exchange buyer in a seven-day escrow.
Hanley Investment Group's Executive Vice President Kevin Fryman and…
Huntington's Disease | Clinical Landscape, Key Companies, Therapeutic Assessment …
DelveInsight's, "Huntington's Disease - Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Huntington's Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight's analysis, the Huntington's Disease pipeline features more…
Hyperuricemia: Clinical Overview, Company Landscape, Therapeutic Evaluation, Tre …
DelveInsight's, "Hyperuricemia - Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Hyperuricemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, more than 10 prominent companies are actively developing over…
Hypoglycemia: Clinical Overview, Company Landscape, Therapeutic Evaluation, Trea …
DelveInsight's, "Hypoglycemia - Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Hypoglycemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, over 10 major companies are actively engaged in developing…
More Releases for Axillary
Axillary Crutches Market Size 2024 to 2031.
Market Overview and Report Coverage
Axillary crutches are commonly used mobility aids to assist individuals in walking when they have difficulty bearing weight on their legs or feet. These crutches are designed with padded axillary supports that rest under the arms and provide support while walking.
The Axillary Crutches Market is expected to witness significant growth in the coming years, with a projected CAGR of 12.20% during the forecasted…
Massive Growth in Axillary Crutches Market, 2021-2026
(Portland, United States): Big Market Research newly added a research report on the Axillary Crutches Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in…
Axillary Crutches Market - Size, Share, Outlook, and Opportunity
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be…
Axillary Crutches Market - Size, Share, Outlook, and Opportunity Analysis, 2018 …
Axillary crutches are the mobility aids used by individuals suffering from walking disability, factures, paralysis, and leg injuries. Axillary crutches transfer the weight from legs to the arms/shoulders and support the movement of individuals who are unable to walk due to some disability. Axillary crutches are lightweight and they are available in various materials, which includes aluminum, stainless steel, and wooden. Axillary crutches are adjustable in size and can be…
Global Axillary Crutches Market: Top Players - Invacare, Stander, Sizewise
Latest industry research report on: Global Axillary Crutches Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1001065
This report studies sales (consumption) of Axillary Crutches in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Millennial Medical
Ergoactives
Cardinal Health
AMG Medical Inc/Airgo
Carex
Graham Field
Nova…
Global Axillary Crutches Market Research Report 2017
Report Hive Market Research Released a New Research Report of 102 pages on Title " Global Axillary Crutches Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Axillary Crutches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
